Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma.
about
Immunostimulatory Gene Therapy Using Oncolytic Viruses as VehiclesSunitinib: the antiangiogenic effects and beyondImmunological effect of local ablation combined with immunotherapy on solid malignancies.Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.Clinical and kinomic analysis identifies peripheral blood mononuclear cells as a potential pharmacodynamic biomarker in metastatic renal cell carcinoma patients treated with sunitinib.A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.Improving cancer immunotherapy with DNA methyltransferase inhibitors.Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.Unleashing the immune response against childhood solid cancers.Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer.Adoptive T cell therapy: An overview of obstacles and opportunities.The immune contexture in cancer prognosis and treatment.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaHarness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.Circulating CD14+ HLA-DR-/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery.Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
P2860
Q26777403-4B16D569-C6CD-4CB2-BC78-52CFD5BFE285Q28066499-0AE21E6C-0E9C-4E35-8CB1-2F9F722C1898Q30354580-B34104D5-C97B-432A-ACE4-55EDF53723B7Q37014134-38E735BD-E14C-4412-986C-277B8BF9FEB0Q37687194-B7FB8810-255C-4D0F-BA3E-61B554987DC9Q38373731-4B2F183A-BFD7-4CEF-A829-3CD4BED766A9Q38662760-4933049A-7A51-4BC6-825F-19DA916E5C81Q38776701-FA1EE69F-D7E1-47D3-9504-2972BF3F722FQ38847251-0140F5F9-EE2D-431D-BC19-C9654214FDA8Q39034031-E839ED48-555D-43B0-A33B-327B873F291CQ39224315-8B442283-A47E-4A29-B462-4AD5BD828229Q39236837-B7BB431E-44D3-4916-BFBC-A641B6FEC0E9Q39329596-F68A11CF-154A-4653-8418-A9A88FC4A240Q39456999-F4EE96B1-CE03-4E93-AB45-0F9F5ADF6703Q40032613-19FFF77C-69C4-40F9-BDA1-CFDC0EAC75E2Q46540302-955F3FBC-7857-46E4-9D02-770F4E054119Q47136084-E2E216AA-1B53-42AA-B034-7AE61027AE88Q49884887-88D6DAE8-9983-40EA-8B8E-14A64C8D7D01Q51759802-82A9F92F-F9D8-4BD2-ACDD-D5789B830676Q52758913-FC48897D-6EFB-49E2-B645-2C934168DD07Q57817490-F4189365-DFC3-47E3-A441-310034E1E8CD
P2860
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sunitinib pretreatment improve ...... in human renal cell carcinoma.
@en
type
label
Sunitinib pretreatment improve ...... in human renal cell carcinoma.
@en
prefLabel
Sunitinib pretreatment improve ...... in human renal cell carcinoma.
@en
P2093
P2860
P1476
Sunitinib pretreatment improve ...... in human renal cell carcinoma.
@en
P2093
Andrew Kaiser
Aurelie Guislain
Christian U Blank
Ekaterina S Jordanova
Hester van Boven
John B A G Haanen
Joyce Sanders
Jules Gadiot
Tanja D de Gruijl
P2860
P2888
P304
P356
10.1007/S00262-015-1735-Z
P577
2015-06-24T00:00:00Z
P6179
1023334578